舒利迭吸入与普米克联合喘康速吸入治疗儿童哮喘疗效对比观察
出处
《河北医药》
CAS
2007年第11期1208-1209,共2页
Hebei Medical Journal
参考文献5
-
1儿童哮喘防治常规(试行)[J].中华儿科杂志,1998,36(12):747-751. 被引量:2373
-
2刘春涛,黎联,梁宗安,滕鸿.吸入激素联合长效β_2受体激动剂治疗哮喘6个月疗效观察[J].中国呼吸与危重监护杂志,2004,3(4):241-244. 被引量:18
-
3刘秀林,林红伍,马薇.舒利迭治疗支气管哮喘30例疗效观察[J].天津医科大学学报,2004,10(3):441-442. 被引量:11
-
4韩志英,刘爱红.舒利迭吸入治疗儿童哮喘疗效观察[J].中国药物与临床,2004,4(8):627-629. 被引量:10
-
5李雅莉,孙秀珍,张洁.舒利迭治疗哮喘的临床观察[J].医师进修杂志,2003,26(10):28-28. 被引量:7
二级参考文献25
-
1[2]Johnson M. The beta adrenoceptor. Am J Respir Crit Care Med,1998, 158: S146-153.
-
2[3]Green SA, Spasoff AP, Coleman RA, et al. Sustained activation of a G protein-coupled receptor via ″anchored″ agonist binding.Molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J Biol Chem, 1996, 271: 24029-24035.
-
3[4]Mak JC, Nishikawa M, Barnes PJ.Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol, 1995, 268: 241-246.
-
4[5]Baraniuk JN, Ali M, Brody D, et al. Glucocorticoids induce beta 2-adrenergic receptor function in human nasal mucosa. Am J Respir Crit Care Med, 1997, 155: 704-710.
-
5[6]Eickelberg O, Roth M, Lorx R, et al. Ligand-independent activation of the glucocorticoid receptor by beta 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem, 1999, 274: 1005-1010.
-
6[7]Condemi JJ, Stanley G, Christopher K, et al. The addition of salmeterol of fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Ann Allergy Asthma Immunol, 1999, 82: 383-389.
-
7National institutes of health,National Heart,Lung and Blood Institutes.Global strategy for asthma management and prevention.Revised,2002
-
8Kemp JP,DeGraff AC Jr,Pearlman DS,et al.A 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholine.J Allergy Clin Immunol,1999;104:1189-1197
-
9O'Byrne PM,Barnes PJ,Rodriguez-Roisin R,et al.Low dose inhaled budesonide and formoterol in mild persistent asthma:the OPTIMA randomized trial.Am J Respir Crit Care Med,2000;164(8Pt1):1392-1399
-
10Calverley P,Pauwels R,Vestbo J,Jones P,et al.Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease:a randomised controlled trial.Lancet,2003;361(9356):449-456
共引文献2404
-
1郭烁,王红霞,黄玲玲,张海涛,张娜娜,孙国强,方朝义.百杏润肺化浊解毒汤对慢性持续期痰浊阻肺型支气管哮喘患者炎症因子及肺功能的影响[J].中药药理与临床,2022,38(1):176-180. 被引量:2
-
2陈珊,郑丽霞.参苓白术颗粒联合利肺片治疗儿童支气管哮喘缓解期45例临床观察[J].中医儿科杂志,2018,0(3):37-40. 被引量:5
-
3刘长连,林勇平,徐韫健,陈德晖,林育能.儿童哮喘急性发作的呼吸道病毒谱分析[J].热带医学杂志,2019,19(10):1197-1200. 被引量:6
-
4肖学成,尹志成,方安雪,俞凤娇.顶空进样气相色谱法测定丙酸氟替卡松中残留有机溶剂[J].医药导报,2015,34(S01):87-88.
-
5陈新宇,边兴茂,陈小芳.支气管哮喘患儿血清TGF-β1和IgE水平的探讨[J].中国实验诊断学,2007,11(11):1542-1543.
-
6谢黔,任小眉,田玉珍,张小宁.小剂量布地奈德治疗儿童哮喘1年后肺功能观察[J].陕西医学杂志,2001,30(11):643-644.
-
7谢庆玲,焦伟,温志红,梅芬娥,胡琼燕,李星.哮喘儿童嗜酸细胞阳离子蛋白含量变化与其肺功能的关系[J].陕西医学杂志,2001,30(11):645-646.
-
8赵顺英,戚豫,刘玺诚,江沁波,刘世英,姜英,江载芳.核因子-κB在哮喘患儿支气管上皮细胞的活化及意义[J].中华儿科杂志,2001,39(1):38-40. 被引量:6
-
9温燕铭,文梦灵,陈妙盈.对哮喘儿童及家长进行多样化健康教育的体会[J].当代护士(中旬刊),2006,13(10):83-84. 被引量:1
-
10陈照梅,黄蝶卿.支气管哮喘患儿实施有效健康教育的方法[J].当代护士(中旬刊),2005,12(8):76-78. 被引量:1
-
1韩鸣,宋明月,翟丽云.布地奈德联合福莫特罗对儿童哮喘急性发作时肺功能的影响[J].现代医药卫生,2012,28(9):1345-1346.
-
2韩志英,刘爱红.舒利迭吸入治疗儿童哮喘疗效观察[J].中国药物与临床,2004,4(8):627-629. 被引量:10
-
3王靖.消旋卡多曲治疗婴幼儿腹泻病临床观察[J].中国药师,2010,13(5):717-718. 被引量:1
-
4余声华.吸入型糖皮质激素治疗儿童哮喘的临床应用[J].实用儿科临床杂志,2004,19(12):1018-1020. 被引量:36
-
5陶茂进.雾化吸入布地奈德混悬液+吸入型特布他林治疗儿童哮喘急性发作的疗效观察[J].实用临床医学(江西),2009,10(9):85-86. 被引量:7
-
6张映波,陆英.布地奈德粉吸入剂吸入治疗儿童哮喘68例临床分析[J].中国基层医药,2011,18(13):1845-1846. 被引量:3
-
7罗厚江,潘家华,倪陈,计明红,陈云龙,王珅,陈伟.合并结核感染的支气管哮喘儿童临床治疗研究[J].安徽医学,2010,31(5):442-445. 被引量:5
-
8袁萍.舒利迭吸入治疗支气管哮喘的护理要点[J].中国实用医药,2010,5(1):179-180. 被引量:4
-
9姚亚民.锌硒宝防治小儿感染性哮喘36例疗效观察[J].山东医药,2006,46(19):93-93. 被引量:1
-
10马兆越,林荣军.吸入性糖皮质激素对哮喘患儿血清1,25-(OH)_2D_3、皮质醇及促肾上腺皮质激素水平的影响[J].儿科药学杂志,2015,21(4):1-3. 被引量:7